Evaluation of Patterns and Correlations of the Degree of Conjunctival Hyperemia Induced by Omidenepag Isopropyl 0.002% and Ripasudil 0.4%

Ítems similars

• Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4%
  per: Terao, Etsuko, et al.
  Publicat: (2020)
• One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl
  per: Oogi, Satomi, et al.
  Publicat: (2020)
• Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
  per: Sakamoto, Emi, et al.
  Publicat: (2019)
• Objective hyperemia and intraocular pressure changes following omidenepag isopropyl application.
  per: Kana Tokumo, et al.
  Publicat: (2025-01-01)
• A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
  per: Olander, Kenneth W., et al.
  Publicat: (2021)